BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23641421)

  • 1. Building better biotherapeutics and vaccines by design: EpiVax, Inc., an immunology company.
    Moise L; De Groot A; Marcello A; Tassone R; Martin W; Cousens L
    R I Med J (2013); 2013 Feb; 96(2):19-21. PubMed ID: 23641421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Showcasing bioscience in Rhode Island.
    Spero D
    R I Med J (2013); 2013 Feb; 96(2):15. PubMed ID: 23641419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VeroScience: applying nature's genius to help improve the human condition.
    R I Med J (2013); 2013 Feb; 96(2):29-31. PubMed ID: 23641424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Tregitopes have the potential to impact the current treatment landscape of autoimmune diseases?
    De Groot AS
    Expert Rev Clin Immunol; 2013 Dec; 9(12):1155-7. PubMed ID: 24215404
    [No Abstract]   [Full Text] [Related]  

  • 5. Immuno-informatics: Mining genomes for vaccine components.
    De Groot AS; Sbai H; Aubin CS; McMurry J; Martin W
    Immunol Cell Biol; 2002 Jun; 80(3):255-69. PubMed ID: 12067413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New tools, new approaches and new ideas for vaccine development.
    De Groot AS; Moise L
    Expert Rev Vaccines; 2007 Apr; 6(2):125-7. PubMed ID: 17408360
    [No Abstract]   [Full Text] [Related]  

  • 7. Further progress on defining highly conserved immunogenic epitopes for a global HIV vaccine: HLA-A3-restricted GAIA vaccine epitopes.
    De Groot AS; Levitz L; Ardito MT; Skowron G; Mayer KH; Buus S; Boyle CM; Martin WD
    Hum Vaccin Immunother; 2012 Jul; 8(7):987-1000. PubMed ID: 22777092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial overview: Immunomodulation: New insights for future treatments.
    Anderton SM; Fillatreau S
    Curr Opin Pharmacol; 2015 Aug; 23():vii-ix. PubMed ID: 26143969
    [No Abstract]   [Full Text] [Related]  

  • 9. CD4+ T cell epitope discovery and rational vaccine design.
    Rosa DS; Ribeiro SP; Cunha-Neto E
    Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):121-30. PubMed ID: 20155490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells: from bench to bedside.
    Jiang S
    Int Immunopharmacol; 2009 May; 9(5):515-7. PubMed ID: 19272465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From immunome to vaccine: epitope mapping and vaccine design tools.
    De Groot AS; Martin W
    Novartis Found Symp; 2003; 254():57-72; discussion 72-6, 98-101, 250-2. PubMed ID: 14712932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoinformatics and the prediction of immunogenicity.
    Flower DR; Doytchinova IA
    Appl Bioinformatics; 2002; 1(4):167-76. PubMed ID: 15130835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The year in immunology 2. Preface.
    Rose NR
    Ann N Y Acad Sci; 2010 Jan; 1183():vii-viii. PubMed ID: 20146703
    [No Abstract]   [Full Text] [Related]  

  • 14. The Immunotherapeutics & Vaccine Summit--CHI's fourth annual meeting. Preclinical/clinical development of immunotherapies and vaccines. 17-19 August 2009, Providence, RI, USA.
    Butterfield LH
    IDrugs; 2009 Oct; 12(10):633-5. PubMed ID: 19790013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational vaccinology and epitope vaccine design by immunoinformatics.
    Khalili S; Jahangiri A; Borna H; Ahmadi Zanoos K; Amani J
    Acta Microbiol Immunol Hung; 2014 Sep; 61(3):285-307. PubMed ID: 25261943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivering the promise of the Decade of Vaccines: opportunities and challenges in the development of high quality new vaccines.
    Keith JA; Agostini Bigger L; Arthur PA; Maes E; Daems R
    Vaccine; 2013 Apr; 31 Suppl 2():B184-93. PubMed ID: 23598480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope-driven DNA vaccine design employing immunoinformatics against B-cell lymphoma: a biotech's challenge.
    Iurescia S; Fioretti D; Fazio VM; Rinaldi M
    Biotechnol Adv; 2012; 30(1):372-83. PubMed ID: 21745560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ProThera Biologics, Inc.: a novel immunomodulator and biomarker for life-threatening diseases.
    Lim YP
    R I Med J (2013); 2013 Feb; 96(2):16-8. PubMed ID: 23641420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomics: discovering new targets for vaccines and therapeutics.
    De Groot AS
    Drug Discov Today; 2006 Mar; 11(5-6):203-9. PubMed ID: 16580597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoinformatics and modeling perspective of T cell epitope-based cancer immunotherapy: a holistic picture.
    Mishra S; Sinha S
    J Biomol Struct Dyn; 2009 Dec; 27(3):293-306. PubMed ID: 19795913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.